مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

297
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

71
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

THE SERUM AMYLOID β LEVEL IN MULTIPLE SCLEROSIS: A CASE- CONTROL STUDY

Pages

  214-221

Abstract

 Background: MULTIPLE SCLEROSIS (MS) is one of the most common autoimmune diseases in adults that cause disability in patients. Different studies were conducted on more rapid diagnosis of the disease such as measuring serum or cerebrospinal fluid (CSF) contents.Objectives: The current study aimed at measuring AMYLOID b (Ab) serum levels in patients with relapsing-remitting MS.Materials and Methods: In the current case-control study, the serum levels of A were measured in 48 patients with RRMS and 33 healthy controls using the ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) technique in Isfahan, Iran, from 2014 to 2016. Data analysis was conducted with SPSS.Results: The mean serum level of Ab in the case (patients with RRMS) and control groups were 192.75±125.65 and 128.11±85.20 pg/mL, respectively; so serum Ab levels in the RRMS group was significantly higher than healthy controls (p=0.02). Also, there was a positive significant correlation between the serum Ab levels and the expanded disability status scale (EDSS) (r=+0.85, p<0.0001).Conclusions: Owing to the increase of serum Ab level in patients with RRMS and its significant increase in severe MS cases (higher EDSS scores), so serum Ablevel can be considered as a marker for MS and its progression.

Cites

References

  • No record.
  • Cite

    APA: Copy

    ETEMADIFAR, MASOUD, GHADIMI, MOZHGAN, GHADIMI, KEYVAN, & ALSAHEBFOSOUL, FERESHTEH. (2017). THE SERUM AMYLOID β LEVEL IN MULTIPLE SCLEROSIS: A CASE- CONTROL STUDY. CASPIAN JOURNAL OF NEUROLOGICAL SCIENCES, 3(11), 214-221. SID. https://sid.ir/paper/344661/en

    Vancouver: Copy

    ETEMADIFAR MASOUD, GHADIMI MOZHGAN, GHADIMI KEYVAN, ALSAHEBFOSOUL FERESHTEH. THE SERUM AMYLOID β LEVEL IN MULTIPLE SCLEROSIS: A CASE- CONTROL STUDY. CASPIAN JOURNAL OF NEUROLOGICAL SCIENCES[Internet]. 2017;3(11):214-221. Available from: https://sid.ir/paper/344661/en

    IEEE: Copy

    MASOUD ETEMADIFAR, MOZHGAN GHADIMI, KEYVAN GHADIMI, and FERESHTEH ALSAHEBFOSOUL, “THE SERUM AMYLOID β LEVEL IN MULTIPLE SCLEROSIS: A CASE- CONTROL STUDY,” CASPIAN JOURNAL OF NEUROLOGICAL SCIENCES, vol. 3, no. 11, pp. 214–221, 2017, [Online]. Available: https://sid.ir/paper/344661/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button